312325-75-0Relevant articles and documents
NOVEL FERROPORTIN INHIBITORS
-
Page/Page column 331, (2017/05/10)
The invention relates to novel ferroportin inhibitors of the general formula (I) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.
BICYCLIC AZA-AMIDES FOR TREATMENT OF PSYCHIATRIC DISORDERS
-
Page/Page column 34; 35, (2014/02/16)
The present invention relates to compounds of formula (I) having a bicyclic aza-amides scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said bicyclic aza- amides compounds can be used for prophylaxis and/or treatment of psychiatric disorders and neurodegenerative diseases, disorders and conditions.
Facile cyanomethylation of bromopyridines by nucleophilic substitution with lithioacetonitrile
Skerlj,Bogucki,Bridger
, p. 1488 - 1490 (2007/10/03)
Substituted bromopyridines undergo facile nucleophilic substitution with lithioacetonitrile under mild conditions to afford the corresponding cyanomethylated products.